The American Journal of Medicine
Volume 122, Issue 12 , Pages 1122-1127 , December 2009

Obstructive Sleep Apnea as a Risk Factor for Type 2 Diabetes

  • Nader Botros, MD, MPH

      Affiliations

    • Division of Pulmonary, Critical Care, and Sleep Medicine, Yale University School of Medicine, New Haven, Conn
  • ,
  • John Concato, MD

      Affiliations

    • Division of General Internal Medicine, Yale University School of Medicine, New Haven, Conn
    • Clinical Epidemiology Research Center (CERC), Veterans Affairs Connecticut Healthcare System, West Haven
  • ,
  • Vahid Mohsenin, MD

      Affiliations

    • Division of Pulmonary, Critical Care, and Sleep Medicine, Yale University School of Medicine, New Haven, Conn
  • ,
  • Bernardo Selim, MD

      Affiliations

    • Division of Pulmonary, Critical Care, and Sleep Medicine, Yale University School of Medicine, New Haven, Conn
  • ,
  • Kervin Doctor, MD

      Affiliations

    • Clinical Epidemiology Research Center (CERC), Veterans Affairs Connecticut Healthcare System, West Haven
  • ,
  • Henry Klar Yaggi, MD, MPH

      Affiliations

    • Division of Pulmonary, Critical Care, and Sleep Medicine, Yale University School of Medicine, New Haven, Conn
    • Clinical Epidemiology Research Center (CERC), Veterans Affairs Connecticut Healthcare System, West Haven
    • Corresponding Author InformationRequests for reprints should be addressed to Henry Klar Yaggi, MD, MPH, Department of Internal Medicine, Yale University School of Medicine, 300 Cedar St., TAC 441s, P.O. Box 208057, New Haven, CT 06520

References 

  1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2005;28(Suppl 1):S37–S42
  2. Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328:1230–1235
  3. Drager LF, Bortolotto LA, Figueiredo AC, et al. Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med. 2007;176:706–712
  4. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005;365(9464):1046–1053
  5. Peppard P, Young T, Palta M, Skatrud JB. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000;342:1378–1384
  6. Yaggi H, Concato J, Kernan W, et al. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med. 2005;353:2034–2041
  7. Young T, Finn L, Peppard P, et al. Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep. 2008;31:1071–1078
  8. Punjabi NM, Shahar E, Redline S, et al. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol. 2004;160:521–530
  9. Yaggi HK, Araujo AB, McKinlay JB. Sleep duration as a risk factor for the development of type 2 diabetes. Diabetes Care. 2006;29:657–661
  10. Coughlin SR, Mawdsley L, Mugarza JA, et al. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J. 2004;25:735–741
  11. Ip MS, Lam B, Ng MM, et al. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med. 2002;165:670–676
  12. Meslier N, Gagnadoux F, Giraud P, et al. Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome. Eur Respir J. 2003;22:156–160
  13. Punjabi NM, Sorkin JD, Katzel LI, et al. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med. 2002;165:677–682
  14. Resnick HE, Redline S, Shahar E, et al. Diabetes and sleep disturbances: findings from the Sleep Heart Health Study. Diabetes Care. 2003;26:702–709
  15. Tiihonen M, Partinen M, Narvanen S. The severity of obstructive sleep apnoea is associated with insulin resistance. J Sleep Res. 1993;2:56–61
  16. Johns MW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep. 1991;14:540–545
  17. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research (The Report of an American Academy of Sleep Medicine Task Force). Sleep. 1999;22:667–689
  18. Meoli AL, Casey KR, Clark RW, et al. Hypopnea in sleep-disordered breathing in adults. Sleep. 2001;24:469–470
  19. Rechtschaffen A, Kales A. A Manual of Standardized Terminology, Techniques and scoring System for Sleep Stages of Human Subjects. Los Angeles, CA: UCLA Brain Information Service/Brain Research Institute; 1968;
  20. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2008;31(Suppl 1):S55–S60
  21. Loube DI, Gay PC, Strohl KP, et al. Indications for positive airway pressure treatment of adult obstructive sleep apnea patients: a consensus statement. Chest. 1999;115:863–866
  22. Schoenfeld P. Sample-size formula for the proportional-hazards regression model. Biometrics. 1983;39:499–503
  23. Coughlin SR, Mawdsley L, Mugarza JA, et al. Cardiovascular and metabolic effects of CPAP in obese males with OSA. Eur Respir J. 2007;29:720–727
  24. Reichmuth KJ, Austin D, Skatrud JB, Young T. Association of sleep apnea and type II diabetes: a population-based study. Am J Respir Crit Care Med. 2005;172:1590–1595
  25. West SD, Nicoll DJ, Wallace TM, et al. Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes. Thorax. 2007;62:969–974
  26. West S. Prevalence of obstructive sleep apnea in men with type 2 diabetes. Thorax. 2006;61:945–950
  27. Ficker JH, Dertinger SH, Siegfried W, et al. Obstructive sleep apnoea and diabetes mellitus: the role of cardiovascular autonomic neuropathy. Eur Respir J. 1998;11:14–19
  28. Bottini P. Sleep-disordered breathing in nonobese diabetic subjects with autonomic neuropathy. Eur Respir J. 2003;22:654–660
  29. Al-Delaimy WK, Manson JE, Willett WC, et al. Snoring as a risk factor for type II diabetes mellitus: a prospective study. Am J Epidemiol. 2002;155:387–393
  30. Elmasry A, Janson C, Lindberg E, et al. The role of habitual snoring and obesity in the development of diabetes: a 10-year follow-up study in a male population. J Intern Med. 2000;248:13–20
  31. Marshall NS, Wong KK, Phillips CL, et al. Is sleep apnea an independent risk factor for prevalent and incident diabetes in the Busselton Health Study?. J Clin Sleep Med. 2009;5:15–20
  32. Redline S, Storfer-Isser A, Rosen CL, et al. Association between metabolic syndrome and sleep-disordered breathing in adolescents. Am J Respir Crit Care Med. 2007;176:401–408
  33. Sulit L, Storfer-Isser A, Kirchner HL, Redline S. Differences in polysomnography predictors for hypertension and impaired glucose tolerance. Sleep. 2006;29:777–783
  34. Polotsky VY, Li J, Punjabi NM, et al. Intermittent hypoxia increases insulin resistance in genetically obese mice. J Physiol. 2003;552(Pt 1):253–264
  35. Yamauchi M, Nakano H, Maekawa J, et al. Oxidative stress in obstructive sleep apnea. Chest. 2005;127:1674–1679
  36. Punjabi N. Disorders of glucose metabolism in sleep apnea. J Appl Physiol. 2005;99:1998–2007
  37. Chasens ER, Weaver TE, Umlauf MG. Insulin resistance and obstructive sleep apnea: is increased sympathetic stimulation the link?. Biol Res Nurs. 2003;5:87–96
  38. Somers VK, Mark AL, Abboud FM. Sympathetic activation by hypoxia and hypercapnia—implications for sleep apnea. Clin Exp Hypertens A. 1988;10(Suppl 1):413–422
  39. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest. 1995;96:1897–1904
  40. Babu AR, Herdegen J, Fogelfeld L, et al. Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch Intern Med. 2005;165:447–452
  41. Harsch IA, Schahin SP, Bruckner K, et al. The effect of continuous positive airway pressure treatment on insulin sensitivity in patients with obstructive sleep apnoea syndrome and type 2 diabetes. Respiration. 2004;71:252–259
  42. Harsch IA, Schahin SP, Radespiel-Troger M, et al. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 2004;169:156–162
  43. FA Ribeiro-Filho FF, Azjen S, Zanella MT, Ferreira SR. Methods of estimation of visceral fat: Advantages of ultrasonography. Obes Rev. 2003;11:1488–1494
  44. BW Rossner S, Hiltbrandt E, Hinson W, et al. Adipose tissue determinations in cadavers (A comparison between cross-sectional planimetry and computed tomography). Int J Obes. 1990;14:893–902
  45. Hirshkowitz M, Littner M, Kuna S, et al. Sleep-related Breathing Disorders: Sourcebook. 2nd edition. Milwaukee, WI: Healthcare Analysis & Information Group (HAIG), VHA; 2003;

 Funding: VA Health Services Research and Development/Clinical Science, Career Development Awards to Dr. Yaggi. National Research Service Award Institutional Research Training Grant (5T32HL07778) to Dr. Botros.

 Conflict of Interest: The authors have no relevant conflicts of interest to disclose.

 Authorship: All authors had access to the data and a role in writing the manuscript.

PII: S0002-9343(09)00679-2

doi: 10.1016/j.amjmed.2009.04.026

The American Journal of Medicine
Volume 122, Issue 12 , Pages 1122-1127 , December 2009